ALFA Finder| Value | ₹0.11 Cr |
|---|
BSE filing, NSE: TIRUMALCHM. Summary written from the filing by ALFA Finder's alert engine.
Thirumalai Chemicals Ltd: key numbers
- Share price
- ₹122.77
- Market cap
- ₹1,480 Cr
- Revenue (annual)
- ₹1,736 Cr
- Net profit (annual)
- ₹-167.9 Cr
- P/E (TTM)
- -9.7×Sector 35.1×
- Promoter holding
- 37.13%+0.00% QoQ
- FII holding
- 1.39%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Thirumalai Chemicals Ltd
All →Thirumalai Chemicals Q2 FY27 Results: Net Loss of ₹34.3 Cr, Loss Widens
Thirumalai Chemicals Ltd reported revenue from operations of ₹596.5 Cr (+33.9% YoY) and a net loss of ₹34.3 Cr for Q2 FY27.
- Key figure
- Net loss ₹34.3 Cr
Thirumalai Chemicals Board Meeting Date
Thirumalai Chemicals has informed the exchanges that its board will meet on November 5, 2026. The meeting will consider unaudited results for the quarter and half year ended September 30, 2026.
Thirumalai Chemicals Promoter Reclassification
Thirumalai Chemicals received requests from two promoter group members, Narayan Santhanam and Deepa Ajay, to reclassify 100,000 shares (0.08%) as public. The board will consider the requests at its next meeting.
Thirumalai Chemicals Legal & Regulatory
Thirumalai Chemicals received a customs audit observation demanding Rs. 0.2452 Crore for alleged ineligible export benefits. The company contests the demand as erroneous and insignificant.
- Value
- ₹0.25 Cr
- From
- Assistant Commissioner, Office of Commissioner of Customs Audit Chennai
Thirumalai Chemicals Other Announcement
The company has filed its quarterly shareholding pattern under Regulation 31 for the period ended September 30, 2026.
Thirumalai Chemicals Legal & Regulatory
Thirumalai Chemicals received a tax show cause notice for Rs. 17.31 Crore regarding GST discrepancies for FY 2023-24. The company intends to contest the demand.
- Value
- ₹17.31 Cr
Other legal & regulatory announcements
All →Chennai Meenakshi Multispeciality Hospital Legal & Regulatory
Chennai Meenakshi Multispeciality Hospital disclosed a 10 November 2026 court order impleading co-owners in an eviction petition. Annexure states no immediate quantifiable financial impact.
YES Bank Legal & Regulatory
Yes Bank has filed a review petition in the Supreme Court seeking reconsideration of its AT1 bond write-down judgment. The write-down concerns ₹8,415 crore of bonds.
- Value
- ₹8,415 Cr
Jindal Poly Films Legal & Regulatory
Jindal Poly Films signed a 12-day standstill agreement with an investor and subsidiary JPFL Films to explore an amicable settlement regarding ongoing legal proceedings.
- Execution
- 12 days
Astron Paper & Board Mill Legal & Regulatory
Astron Paper explains its failure to meet filing deadlines (financial results, annual report) due to its ongoing Corporate Insolvency Resolution Process (CIRP).
Ganesh Benzoplast Legal & Regulatory
Ganesh Benzoplast disclosed an ex-parte court order in UC Credit's arbitration application over an alleged guarantee. The order seeks Rs 8.27 Crore security and attaches some properties.
- Value
- ₹8.27 Cr
Natural Capsules Legal & Regulatory
Natural Capsules was fined ₹10,000 each by NSE and BSE for short board-meeting notice. The company has paid the fines and cited a late valuation report.
- Value
- ₹0.00 Cr